These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20372069)

  • 1. SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis.
    Hussenet T; du Manoir S
    Cell Cycle; 2010 Apr; 9(8):1480-6. PubMed ID: 20372069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-Determining Region Y-box 2 Promotes Growth of Lung Squamous Cell Carcinoma and Directly Targets Cyclin D1.
    Li C; He B; Huang C; Yang H; Cao L; Huang J; Hu C
    DNA Cell Biol; 2017 Apr; 36(4):264-272. PubMed ID: 28151013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.
    Hussenet T; Dali S; Exinger J; Monga B; Jost B; Dembelé D; Martinet N; Thibault C; Huelsken J; Brambilla E; du Manoir S
    PLoS One; 2010 Jan; 5(1):e8960. PubMed ID: 20126410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer.
    Mukhopadhyay A; Berrett KC; Kc U; Clair PM; Pop SM; Carr SR; Witt BL; Oliver TG
    Cell Rep; 2014 Jul; 8(1):40-9. PubMed ID: 24953650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.
    Watanabe H; Ma Q; Peng S; Adelmant G; Swain D; Song W; Fox C; Francis JM; Pedamallu CS; DeLuca DS; Brooks AN; Wang S; Que J; Rustgi AK; Wong KK; Ligon KL; Liu XS; Marto JA; Meyerson M; Bass AJ
    J Clin Invest; 2014 Apr; 124(4):1636-45. PubMed ID: 24590290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas.
    Bass AJ; Watanabe H; Mermel CH; Yu S; Perner S; Verhaak RG; Kim SY; Wardwell L; Tamayo P; Gat-Viks I; Ramos AH; Woo MS; Weir BA; Getz G; Beroukhim R; O'Kelly M; Dutt A; Rozenblatt-Rosen O; Dziunycz P; Komisarof J; Chirieac LR; Lafargue CJ; Scheble V; Wilbertz T; Ma C; Rao S; Nakagawa H; Stairs DB; Lin L; Giordano TJ; Wagner P; Minna JD; Gazdar AF; Zhu CQ; Brose MS; Cecconello I; Ribeiro U; Marie SK; Dahl O; Shivdasani RA; Tsao MS; Rubin MA; Wong KK; Regev A; Hahn WC; Beer DG; Rustgi AK; Meyerson M
    Nat Genet; 2009 Nov; 41(11):1238-42. PubMed ID: 19801978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
    Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H
    J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation.
    Wang Y; Tan X; Tang Y; Zhang C; Xu J; Zhou J; Cheng X; Hou N; Liu W; Yang G; Teng Y; Yang X
    Cancer Res; 2019 Sep; 79(17):4466-4479. PubMed ID: 31209059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.
    Fukazawa T; Guo M; Ishida N; Yamatsuji T; Takaoka M; Yokota E; Haisa M; Miyake N; Ikeda T; Okui T; Takigawa N; Maeda Y; Naomoto Y
    Sci Rep; 2016 Feb; 6():20113. PubMed ID: 26846300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX2 and PI3K Cooperate to Induce and Stabilize a Squamous-Committed Stem Cell Injury State during Lung Squamous Cell Carcinoma Pathogenesis.
    Kim BR; Van de Laar E; Cabanero M; Tarumi S; Hasenoeder S; Wang D; Virtanen C; Suzuki T; Bandarchi B; Sakashita S; Pham NA; Lee S; Keshavjee S; Waddell TK; Tsao MS; Moghal N
    PLoS Biol; 2016 Nov; 14(11):e1002581. PubMed ID: 27880766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.
    Brcic L; Sherer CK; Shuai Y; Hornick JL; Chirieac LR; Dacic S
    Am J Clin Pathol; 2012 Nov; 138(5):712-8. PubMed ID: 23086772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX2 and squamous cancers.
    Porter L; McCaughan F
    Semin Cancer Biol; 2020 Dec; 67(Pt 1):154-167. PubMed ID: 32905832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
    Boumahdi S; Driessens G; Lapouge G; Rorive S; Nassar D; Le Mercier M; Delatte B; Caauwe A; Lenglez S; Nkusi E; Brohée S; Salmon I; Dubois C; del Marmol V; Fuks F; Beck B; Blanpain C
    Nature; 2014 Jul; 511(7508):246-50. PubMed ID: 24909994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.
    Kim BR; Coyaud E; Laurent EMN; St-Germain J; Van de Laar E; Tsao MS; Raught B; Moghal N
    Mol Cell Proteomics; 2017 Oct; 16(10):1864-1888. PubMed ID: 28794006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
    Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S
    Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of SOX2 in vulvar intraepithelial neoplasia and squamous cell carcinoma.
    Brustmann H; Brunner A
    Int J Gynecol Pathol; 2013 May; 32(3):323-8. PubMed ID: 23518916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jmjd2c maintains the ALDH
    Wang M; Hu Y; Cai F; Guo L; Mao Y; Zhang Y
    Cancer Biol Ther; 2024 Dec; 25(1):2373447. PubMed ID: 38975736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.
    Justilien V; Walsh MP; Ali SA; Thompson EA; Murray NR; Fields AP
    Cancer Cell; 2014 Feb; 25(2):139-51. PubMed ID: 24525231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.
    Chuang WY; Chang YS; Chao YK; Yeh CJ; Liu YH; Tseng CK; Chang HK; Wan YL; Hsueh C
    Int J Clin Exp Pathol; 2015; 8(8):9248-55. PubMed ID: 26464673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.
    Hur JY; Kim HR; Lee JY; Park S; Hwang JA; Kim WS; Yoon S; Choi CM; Rho JK; Lee JC
    Cell Oncol (Dordr); 2019 Aug; 42(4):449-458. PubMed ID: 30838525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.